Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Are The Current (2025) And Forecast (2029) Sizes Of The Implantable Drug Delivery Devices Market?
The market encompassing implantable drug delivery devices has experienced robust expansion over the preceding years, with projections indicating a rise from its 2024 valuation of $20.65 billion to $21.94 billion by 2025, reflecting a compound annual growth rate of 6.3%. Factors driving this historical expansion include the demographic shift towards an older population, the widespread occurrence of long-term illnesses, heightened consumer understanding, an escalating emphasis on proactive health measures, and the increasing need for tailored medical treatments.
Anticipated for the implantable drug delivery devices sector is a robust expansion in the coming years, with the market valuation projected to reach $30.8 billion by 2029, driven by a compound annual growth rate (CAGR) of 8.8%; this upward trajectory in the projection timeframe is fundamentally supported by factors such as personalized drug administration methods, an increasing necessity for less invasive surgical procedures, escalating spending within the healthcare domain, the worldwide proliferation of medical services, strides in regenerative medicine, and developments in genomic medicine, while prevailing shifts during this period encompass continuous technological breakthroughs, progress in biotechnological applications, the emergence of micro-implants, dosage calibration assisted by artificial intelligence, greater synergy with telehealth services, sophisticated use of biocompatible substances, and general enhancements in drug delivery system engineering.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3303&type=smp
What Are The Main Drivers Boosting The Implantable Drug Delivery Devices Industry’s Expansion?
The escalating occurrence of critical ailments, including cancer, diabetic retinopathy, and various cardiovascular and ongoing conditions, is projected to fuel growth within the market for implantable drug delivery systems. As an illustration of this trend, data from the US government agency, the Centers for Disease Control and Prevention, indicated in March 2024 that reported instances of tuberculosis climbed by 1,295 cases, marking a sixteen percent escalation from 8,320 cases documented in 2022 to 9,615 cases observed in 2023; this inherent capability of implantable drug devices to deliver medication directly to the required site for managing these specific diseases is therefore serving as a significant catalyst for the expansion of the implantable drug delivery devices market.
What Are The Key Segments In The Implantable Drug Delivery Devices Market?
The implantable drug delivery devicesmarket covered in this report is segmented –
1) By Product: Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug-Eluting Stents, Bio-absorbable Stents, Intraocular Stents, Infusion Pumps, Other Applications
2) By Technology: Diffusion, Osmotic, Magnetic, Other Technologies
3) By Application: Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases, Other Applications
Subsegments:
1) By Contraceptive Implants: Hormonal Contraceptive Implants, Non-hormonal Contraceptive Implants
2) By Spinal Implants: Biodegradable Spinal Implants, Non-biodegradable Spinal Implants
3) By Brachytherapy Seeds: Iodine-125 Seeds, Palladium-103 Seeds, Cesium-131 Seeds, Other Brachytherapy Seeds
4) By Drug-Eluting Stents: Coronary Drug-Eluting Stents, Peripheral Drug-Eluting Stents
5) By Bio-absorbable Stents: Polymer-based Bio-absorbable Stents, Metal-based Bio-absorbable Stents
6) By Intraocular Stents: Glaucoma Intraocular Stents, Cataract Surgery Intraocular Stents
7) By Infusion Pumps: Insulin Pumps, Chemotherapy Infusion Pumps, Pain Management Infusion Pumps, Other Infusion Pumps
8) By Other Applications: Implantable Reservoirs, Implantable Micro-pumps, Implantable Drug Elution Devices
Which Key Trends Are Expected To Influence The Implantable Drug Delivery Devices Market In The Coming Years?
Efforts from both industry players and academic investigators are currently concentrated on engineering advanced substances suitable for additive manufacturing applications, specifically targeting the creation of implantable apparatuses designed for controlled medication release. These materials, employed in technologies like 3D printing, enable the fabrication of highly tailored and accurate systems for dispensing pharmaceuticals; an illustration of this progress emerged in 2022 when research featured in the National Center for Biotechnology Information documented a method involving integrating 3D-printed structural components with externally applied, naturally dissolving films intended to govern the speed at which lipophilic medications are discharged over time.
Which Leading Players Are Enhancing Their Implantable Drug Delivery Devices Market Presence Worldwide?
Major companies operating in the implantable drug delivery devices market include AbbVie Inc., Bayer HealthCare, Medtronic Inc., Nucletron, Boston Scientific Corporation, Abbott Laboratories, Bausch and Lomb Inc., Merck & Co. Inc., Genentech Inc, EyePoint Pharmaceuticals Inc., DSM Biomedical, Delpor Inc., Teleflex Incorporated, 3M Company, Biotronik Inc., Alcon Inc., Terumo Corporation, Endologix Inc., TransEnterix Inc., China Grand Pharmaceutical and Healthcare Holdings, Innocoll Biotherapeutics, Atossa Therapeutics Inc., Intersect ENT, Microchips Biotech, Theradaptive Inc., CollPlant, Intarcia Therapeutics, Glaukos Corporation
Download The Full Report For Exclusive Market Findings:
What Are The Regional Market Dynamics Impacting The Implantable Drug Delivery Devices Industry?
North America was the largest region in the implantable drug delivery devices market in 2024. Asia-Pacific was the second-largest region in the implantable drug delivery devices market report. The regions covered in the implantable drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Request A Customized Version Of The Implantable Drug Delivery Devices Market Report:
https://www.thebusinessresearchcompany.com/customise?id=3303&type=smp
Browse Through More Reports Similar to the Global Implantable Drug Delivery Devices Market 2025, By The Business Research Company
Drug Delivery Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Injectable Drug Delivery Devices Global Market Report 2025
Liposomal Drug Delivery Devices Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model